Suppression of the transforming growth factor-β signaling pathway produces a synergistic effect of combination therapy with programmed death receptor 1 blockade and radiofrequency ablation against hepatic carcinoma in mice

Primary liver cancer (PLC) significantly affects the health of patients globally owing to its high morbidity and low survival rate. Radiofrequency ablation (RFA) has recently been introduced for the clinical treatment of PLC. However, significant immunosuppressive effects are induced by RFA, which l...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xiaoxiang, Gu, Lihu, Lv, Shuyi, Zhang, Meiwu, Zhuang, Luhui, Zhang, Yan, Chen, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162004/
https://www.ncbi.nlm.nih.gov/pubmed/35354382
http://dx.doi.org/10.1080/21655979.2022.2051688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162004/
https://www.ncbi.nlm.nih.gov/pubmed/35354382
http://dx.doi.org/10.1080/21655979.2022.2051688

Ejemplares similares